NHS National Generic Pharmaceuticals - Lenalidomide
This is a contract result notice, not an open opportunity. Details from the official award data.
NHS National Generic Pharmaceuticals- Lenalidomide<br/>Offer reference number: CM/PHG/21/5638<br/>Period of framework agreement: 01/09/2022 to 31/08/2023 (12 months) with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months.<br/>Potential periods of call-offs under the framework agreement:<br/>Lenalidomide:<br/>ALL REGIONS: 01/09/2022 to 31/08/2023 (12 months)
What this notice demands of you
1 named, none in explicit obligation language. Each one is quoted from the notice.
NHS National Generic Pharmaceuticals- Lenalidomide<br/>Offer reference number: CM/PHG/21/5638<br/>Period of framework agreement: 01/09/2022 to 31/08/2023 (12 months) with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months.<br/>Potential periods of call-offs…
Matched against the notice text, so this is a floor — the tender pack will demand things the notice never mentions. “Says must” means the quoted sentence itself used obligation language; anything ambiguous is left as a mention.
Make the case to bid
Reveal who to approach at NHS England, and generate a go-to-market strategy from their news, accounts and people.
Free to start. Named contacts come from published notices; the strategy is generated from the buyer’s news, accounts and people.
- OCID
- ocds-h6vhtk-02ee98
- Stage
- award · Awarded
- Source
- Find a Tender
- Buyer ref
- 027452-2022
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Medical Equipment & Pharmaceuticals
NHS England’s tender network